Carcinoid syndrome with unknown primary: A case report

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 22, Issue 4, 1999, Pages 384-386

  Mahmood, Tallat ^a   Mudad, Raja ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Carcinoid; Unknown primary

Indexed keywords

5 HYDROXYINDOLEACETIC ACID;

ADULT; ARTICLE; CACHEXIA; CARCINOID SYNDROME; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIARRHEA; ENDOCRINE TUMOR; FLUSHING; HUMAN; MALE; METASTASIS; NEUROENDOCRINE DISEASE; TUMOR LOCALIZATION;

5-HYDROXYTRYPTOPHAN; FATAL OUTCOME; HUMANS; HYDROXYINDOLEACETIC ACID; MALE; MALIGNANT CARCINOID SYNDROME; MIDDLE AGED; NEOPLASMS, UNKNOWN PRIMARY; TIME FACTORS;

EID: 0033502941     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199908000-00012     Document Type: Article

References (12)

1. Modlin IM, Sandor A. An analysis of 8305 cases of carcinoid tumors. Cancer 1997;79:813-29.
2. Memon MA, Nelson H. Gastrointestinal carcinoid tumors current management strategies. Dis Colon Rectum 1997;40:1101-18.
3. Jensen RT, Norton JA. Carcinoid tumors and the carcinoid syndrome. In: De Vita VT, Hellman S, Rosenberg SA, eds. Cancer principles and practice of oncology. 5th ed. Philadelphia: JB Lippincott, 1997:2344-87.
4. Krempf M, Lumbroso J, Mornex R, et al. Use of m-(131) iodobenzylguanidine in the treatment of malignant pheochromocytoma. J Clin Endocrinol Metab 1991;72:455-61.
5. Hoefnagel CA, den Hartog Jager FC, Taal BG, Abeling NG, Engelsman EEJ. The role of I-131-MIBG in the diagnosis and therapy of carcinoid. Eur J Nucl Med 1987;13:187-91.
6. Moertel CG, Johnson CM, McKusick MA, et al. The management of patients with advanced carcinoid tumors and islet cell carcinomas. Ann Int Med 1994;120:302-9.
7. Bajetta E, Rimassa L, Carnaghi C, et al. 5-Fluorouracil, dacarbazine, and epirubicin in the treatment of patients with neuroendocrine tumors. Cancer 1998;83:372-8.
8. Ollivier S, Fonck M, Becouarn Y, Brunet R, Dacarbazine, fluorouracil, and leucovorin in patients with advanced neuroendocrine tumors: a phase II trial. Am J Clin Oncol 1998;21:237-40.
9. Hatton MO, Reed NS. Chemotherapy for neuroendocrine tumors: the Beatson Oncology Center experience. Clin Onc 1997;9:385-9.
10. Faiss S, Scherubl H, Riecken EO, Wiedenmann B. Drug therapy in metastatic neuroendocrine tumors of the gastroenteropancreatic system. Recent Results Cancer Res 1996;142:193-207.
11. Di Bartolomeo M, Bajetta E, Bochicchio AM, et al. A phase II trial of dacarbazine, fluorouracil and epirubicin in patients with neuroendocrine tumors. Ann Onc 1995;6:77-9.
12. Oberg K. The use of chemotherapy in the management of neuroendocrine tumors. Endocrinol Metab Clin North Am 1993;22: 941-52.